Concepedia

Publication | Open Access

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)

DOIFull Paper Access

56

Citations

16

References

2008

Year

Larisa Rudenko, Yulia Desheva, Sergey A. Korovkin, Andrey Rekstin, Elena Grigorieva, Svetlana Donina, Alexandra Gambaryan, Anton Katlinsky
Influenza and Other Respiratory Viruses

Abstract

The live attenuated influenza vaccine candidate prepared using the LPAI A(H5N2) strain was well tolerated and elicited serum and local immune responses. There was evident cross-reactivity to the A(H5N1) strain in the HAI test.

References

YearCitations

Page 1